Document:

exv10w15

 

Exhibit 10.15

VOTING AGREEMENT

AND IRREVOCABLE PROXY

     THIS VOTING AGREEMENT (this “Agreement”) is entered into on the dates executed by the parties
to be effective as of July 1, 2005, by and among Lifeline Therapeutics, Inc., a Colorado
corporation (“Company”), and William Driscoll (the “Shareholder”).

PRELIMINARY STATEMENTS

     WHEREAS, Company and Shareholder have entered into an Agreement, dated July 1, 2005, by and
between Company and Shareholder (the “Severance Agreement”) whereby Shareholder resigned from his
position as President and Chief Executive Officer of Company and Company agreed to provide certain
separation benefits, including severance pay;

     WHEREAS, in the Severance Agreement, Shareholder agreed to the execution and delivery of this
Agreement as part of Shareholder’s consideration for receiving the separation benefits; and

     WHEREAS, Company and Shareholder desire to enter into this Agreement to set forth their
current agreements and understandings with respect to how shares of Company’s class A common stock
held by Shareholder (the “Shares”) will be voted.

STATEMENT OF AGREEMENT

     NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as
follows:

     1. Voting Provisions.

          1.1 Transfer of Voting Rights. Shareholder hereby grants to the Chairman of the Board
of Directors of Company (the “Board”) the irrevocable right to vote the Shares and any New Shares
(as defined below) at every meeting of the shareholders of Company and at every adjournment
thereof, and on every action or approval by written consent of the shareholders of Company.

          1.2 Additional Share Purchases. Shareholder agrees that any shares of capital stock
of Company that Shareholder purchases or with respect to which Shareholder otherwise acquires
record or beneficial ownership (“New Shares”) after the execution of this Agreement and prior to
the termination of this Agreement (including through the exercise of any stock options, warrants or
similar instruments) shall be subject to the terms and conditions of this Agreement to the same
extent as if they constituted Shares.

     2. Irrevocable Proxy. THE SHAREHOLDER HEREBY GRANTS TO AND APPOINTS THE CHAIRMAN OF
THE BOARD, AS SUCH SHAREHOLDER’S SOLE AND

 

 

EXCLUSIVE PROXY AND ATTORNEY-IN-FACT (WITH FULL POWER OF
SUBSTITUTION) TO VOTE OR TO ACT BY WRITTEN CONSENT, IN EACH CASE TO THE FULLEST EXTENT PERMITTED BY
AND SUBJECT TO APPLICABLE LAW, THE SHARES AND ANY NEW SHARES IN RESPECT OF ANY MATTER. THIS PROXY
IS COUPLED WITH AN INTEREST AND SHALL BE IRREVOCABLE THROUGH THE TERMINATION DATE (AS DEFINED
BELOW). THE SHAREHOLDER FURTHER AGREES TO TAKE SUCH OTHER ACTION AND EXECUTE SUCH OTHER
INSTRUMENTS, IN EACH CASE AS MAY BE NECESSARY TO EFFECTUATE THE INTENT OF THIS VOTING AGREEMENT AND
IRREVOCABLE PROXY, AND HEREBY REVOKES ANY PROXY PREVIOUSLY GRANTED BY THE SHAREHOLDER WITH RESPECT
TO THE SHARES OR ANY NEW SHARES THAT IS INCONSISTENT WITH THE INTENT HEREOF.

     3. Successors in Interest. Provisions of this Agreement shall be binding upon the
successors in interest to any of the Shares held by Shareholder to whom a transfer of such stock is
made; provided, however, that this Agreement shall not be binding upon any successor in interest to
any of the Shares if such Shares were purchased in a “brokers’ transaction” as defined in Rule
144(g) of the Securities Act of 1933, as amended.

     4. General Provisions.

          4.1 Termination. This Agreement shall terminate on July 1, 2015 (the “Termination
Date”).

          4.2 Amendment. This Agreement shall only be amended by the written agreement of
Company and Shareholder.

          4.3 Governing Law. The construction, validity and interpretation of this Agreement
shall be governed by the internal laws of the State of Colorado without giving effect to any choice
of law or conflict of law provision or rule (whether of the State of Colorado or any other
jurisdiction) that would cause the application of the laws of any jurisdiction other than the State
of Colorado.

          4.4 Counterparts. This Agreement may be executed in one or more counterparts, each of
which shall be deemed to be an original, but all of which shall be one and the same document.

          4.5 Reorganization. The provisions of this Agreement shall apply to any shares or
other securities resulting from any stock split or reverse split, stock dividend, reclassification,
subdivision, consolidation or reorganization of any shares or other equity securities of Company
and to any shares or other securities of Company or of any successor company which may be received
by Shareholder by virtue of his ownership of the Shares or any New Shares.

          4.6 Headings. The headings of this Agreement are for convenience only and do not
constitute a part of this Agreement.

2

 

          4.7 Severability. The invalidity or unenforceability of any provision of this
Agreement shall not affect the validity or enforceability of any other provision of this Agreement.

          4.8 Further Assurances. Each of the parties hereto shall execute and deliver all
additional documents and instruments and shall do any and all acts and things reasonably requested
in connection with the performance of the obligations undertaken in this Agreement and/or otherwise
to effectuate in good faith the intent of the parties.

          4.9 Binding Effect. The rights and obligations of each party under this Agreement
shall be specifically applicable to and enforceable against any transferees of the parties hereto.

          4.10 Entire Agreement. This Agreement is intended to be the sole agreement of the
parties as it relates to this subject matter and does hereby supersede all other agreements of the
parties relating to the subject matter hereof.

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written.

	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	LIFELINE THERAPEUTICS, INC.	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Dated:
	 	4 - 4 - 06	 	 	 	By:	 	/s/ Stephen K. Onody	 	 
	 

	 	 
	 	 	 	Name:	 	 
Stephen
K. Onody
	 	 
	 
	 	 	 	 	 	Title:	 	CEO 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Dated:
	 	4 - 7 - 06	 	 	 	 	 	/s/ Bill Driscoll	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	William Driscoll	 	 

3exv10w16

 

Exhibit 10.16

VOTING AGREEMENT

AND IRREVOCABLE PROXY

     THIS VOTING AGREEMENT (this “Agreement”) is entered into as of February 9, 2006, by and among
Lifeline Therapeutics, Inc., a Colorado corporation (“Company”), Paul Myhill, and Lisa Gail Myhill.
Paul Myhill and Lisa Gail Myhill are referred to collectively in this Agreement as the
“Shareholders”.

PRELIMINARY STATEMENTS

     WHEREAS, Company and Paul Myhill have entered into an Agreement, dated 9, 2006, by and between
Company and Myhill (the “Consultant Agreement”) whereby Paul Myhill resigned from his position with
the Company and will act as a consultant for the Company;

     WHEREAS, Lisa Gail Myhill, the wife of Paul Myhill, benefits from the payments received by
Paul Myhill under the Consultant Agreement;

     WHEREAS, in connection with the Consultant Agreement, Shareholder has agreed to the execution
and delivery of this Agreement as part of the consideration for the Shareholders’ receiving the
benefits from the Consultant Agreement; and

     WHEREAS, Company and the Shareholders desire to enter into this Agreement to set forth their
current agreements and understandings with respect to how shares of Company’s class A common stock
held by either or both of the Shareholders (the “Shares”) will be voted.

STATEMENT OF AGREEMENT

     NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as
follows:

     1. Voting Provisions.

          1.1 Transfer of Voting Rights. Each of the Shareholders hereby grants to the Chairman
of the Board of Directors of Company (the “Board”) the irrevocable right to vote the Shares and any
New Shares (as defined below) at every meeting of the shareholders of Company and at every
adjournment thereof, and on every action or approval by written consent of the shareholders of
Company. 

          1.2 Additional Share Purchases. Each of the Shareholders agrees that any shares of
capital stock of Company that either or both Shareholders purchases or with respect to which either
or both Shareholders otherwise acquires record or beneficial ownership (“New Shares”) after the
execution of this Agreement and prior to the termination of this Agreement (including through the
exercise of any stock options, warrants or similar instruments) shall be

 

 

subject to the terms and
conditions of this Agreement to the same extent as if they constituted Shares.

     2. Irrevocable Proxy. EACH OF THE SHAREHOLDERS HEREBY GRANTS TO AND APPOINTS THE
CHAIRMAN OF THE BOARD, AS SUCH SHAREHOLDER’S SOLE AND EXCLUSIVE PROXY AND ATTORNEY-IN-FACT (WITH
FULL POWER OF SUBSTITUTION) TO VOTE OR TO ACT BY WRITTEN CONSENT, IN EACH CASE TO THE FULLEST
EXTENT PERMITTED BY AND SUBJECT TO APPLICABLE LAW, THE SHARES AND ANY NEW SHARES IN RESPECT OF ANY
MATTER. THIS PROXY IS COUPLED WITH AN INTEREST AND SHALL BE IRREVOCABLE THROUGH THE TERMINATION
DATE (AS DEFINED BELOW). EACH OF THE SHAREHOLDERS FURTHER AGREES TO TAKE SUCH OTHER ACTION AND
EXECUTE SUCH OTHER INSTRUMENTS, IN EACH CASE AS MAY BE NECESSARY TO EFFECTUATE THE INTENT OF THIS
VOTING AGREEMENT AND IRREVOCABLE PROXY, AND HEREBY REVOKES ANY PROXY PREVIOUSLY GRANTED BY THAT
SHAREHOLDER WITH RESPECT TO THE SHARES OR ANY NEW SHARES THAT IS INCONSISTENT WITH THE INTENT
HEREOF.

     3. Successors in Interest. Provisions of this Agreement shall be binding upon the
successors in interest to any of the Shares held by each of the Shareholders to whom a transfer of
such stock is made; provided, however, that this Agreement shall not be binding upon any successor
in interest to any of the Shares if such Shares were purchased for full consideration in a
“brokers’ transaction” as defined in Rule 144(g) of the Securities Act of 1933, as amended, or in a
transaction in which a broker-dealer registered with the National Association of Securities Dealers
effected the transaction and received compensation for effecting the transaction.

     4. General Provisions.

          4.1 Termination. This Agreement shall terminate on February 7, 2016 (the “Termination
Date”).

          4.2 Amendment. This Agreement shall only be amended by the written agreement of
Company and Shareholder.

          4.3 Governing Law. The construction, validity and interpretation of this Agreement
shall be governed by the internal laws of the State of Colorado without giving effect to any choice
of law or conflict of law provision or rule (whether of the State of Colorado or any other
jurisdiction) that would cause the application of the laws of any jurisdiction other than the State
of Colorado.

          4.4 Counterparts. This Agreement may be executed in one or more counterparts, each of
which shall be deemed to be an original, but all of which shall be one and the same document.

          4.5 Reorganization. The provisions of this Agreement shall apply to any shares or
other securities resulting from any stock split or reverse split, stock dividend, reclassification,
subdivision, consolidation or reorganization of any shares or other equity

2

 

          securities of Company
and to any shares or other securities of Company or of any successor company which may be received
by Shareholder by virtue of his ownership of the Shares or any New Shares.

          4.6 Headings. The headings of this Agreement are for convenience only and do not
constitute a part of this Agreement.

          4.7 Severability. The invalidity or unenforceability of any provision of this
Agreement shall not affect the validity or enforceability of any other provision of this Agreement.

          4.8 Further Assurances. Each of the parties hereto shall execute and deliver all
additional documents and instruments and shall do any and all acts and things reasonably requested
in connection with the performance of the obligations undertaken in this Agreement and/or otherwise
to effectuate in good faith the intent of the parties.

          4.9 Binding Effect. The rights and obligations of each party under this Agreement
shall be specifically applicable to and enforceable against any transferees of the parties hereto.

          4.10 Entire Agreement. This Agreement is intended to be the sole agreement of the
parties as it relates to this subject matter and does hereby supersede all other agreements of the
parties relating to the subject matter hereof.

[Signature pages follow]

3

 

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written.

	 	 	 	 	 	 	 	 	 
	SHAREHOLDERS:	 	 	 	LIFELINE THERAPEUTICS, INC.	 	 
	 
	 	 	 	 	 	 	 	 
	/s/ Paul Myhill

	 	 	 	By:
	 	/s/ Gerald J. Houston	 	 
	 

Paul Myhill

	 	 	 	 	 	 

Name: Gerald J. Houston
	 	 
	 

	 	 	 	 	 	Title: CFO	 	 
	 
	 	 	 	 	 	 	 	 
	/s/ Lisa Gail Myhill
	 	 	 	 	 	 	 	 
	 

Lisa Gail Myhill

	 	 	 	 	 	 	 	 

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]